Floatz logo

Azacitidine

Acute Biphenotypic Leukemia

M.D. Anderson Cancer CenterSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

42 Active assets in the Acute Biphenotypic Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 2/3BB
FILGRASTIM
Ossium Health, Inc.
Phase 2BB
Cytosin-Arabinosid
University of Washington
Phase 2BB
Busulphan
Ossium Health, Inc.
Phase 2BB
Thiotepa
Fred Hutchinson Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

Azacitidine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
73 / 100
View asset →
acute erythroid leukemiaDormant
BB
Indicative ·
71 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →